Vol. 2 No. 15: Secondary Leukemias and leukemogenesis Rome, 3-4 November 2006

Published: 2009-06-11

Articles

Secondary leukemias and leukeogenesis

Giuseppe Leone, Maria Teresa Voso, Livio Pagano

https://doi.org/10.4081/hmr.v2i15.512

Published: June 11, 2009

425

PDF: 168
- PDF
Biology of Normal and Leukemic Stem Cells

Dominique Bonnet

https://doi.org/10.4081/hmr.v2i15.513

Published: June 11, 2009

200

PDF: 366
- PDF
Epigenetic pathways in hematological malignancies

Santiago Ropero

https://doi.org/10.4081/hmr.v2i15.514

Published: June 11, 2009

214

PDF: 300
- PDF
Therapy-related myeloid leukemia. A model for leukemogenesis

Michelle M. Le Beau, Richard A. Larson

https://doi.org/10.4081/hmr.v2i15.515

Published: June 11, 2009

168

PDF: 322
- PDF
Gene mutations in the pathogenesis of t-MDS

Jens Pedersen-Bjergaard, Mette K. Andersen, Morten Tolstrup Andersen, Debes H. Christiansen

https://doi.org/10.4081/hmr.v2i15.516

Published: June 11, 2009

202

PDF: 259
- PDF
Ionizing radiation and secondary leukaemia: experimental approaches

Eric G. Wright

https://doi.org/10.4081/hmr.v2i15.517

Published: June 11, 2009

150

PDF: 331
- PDF
The molecular mechanisms of alkylating agent-related acute myeloid leukaemia

James M. Allan

https://doi.org/10.4081/hmr.v2i15.599

Published: June 16, 2009

171

PDF: 1168
- PDF
Translocation Mechanism in Secondary Leukemias Following Topoisomerase II Poisons

Carolyn A. Felix, Blaine W. Robinson, Giuseppe Germano, Christos P. Kolaris, Leslie J. Raffini, Luca Lo Nigro, Emily Roumm, Maureen D. Megonigal, Diana J. Slater, Ryan J. Whitmarsh, Charles Saginario, Brian D. Lovett, Jolanta Libura, Linda D. Pegram

https://doi.org/10.4081/hmr.v2i15.600

Published: June 16, 2009

327

PDF: 414
- PDF
Origin and characteristics of unbalanced chromosome aberrations in therapy-related myelodysplasia and acute myeloid leukemia

Mette K. Andersen, Debes Christiansen, Jens Pedersen-Bjergaard

https://doi.org/10.4081/hmr.v2i15.601

Published: June 16, 2009

184

PDF: 133
- PDF
Defining The Translocation Mechanism In Therapy-Related Acute Promyelocytic Leukaemia

Anita R. Mistry, Ashley Mays, Annabel Mason, Andreas Reiter, Joe Wiemels Wiemels, Mark Segal, Ellen Solomon, Christine Chomienne, Pierre Fenaux, Carolyn Felix, David Grimwade

https://doi.org/10.4081/hmr.v2i15.602

Published: June 16, 2009

207

Untitled: 169
- Untitled
Environmental risk factors for MDS/AML

Livio Pagano, Morena Caira, Luana Fianchi, Giuseppe Leone

https://doi.org/10.4081/hmr.v2i15.603

Published: June 16, 2009

504

PDF: 2029
- PDF
Detoxification enzyme polymorphisms as risk factors fo t-AML

Maria Teresa Voso, Francesco D’Alò, Giuseppe Leone

https://doi.org/10.4081/hmr.v2i15.604

Published: June 16, 2009

240

PDF: 289
- PDF
Secondary Myeloid Leukemia and MDS in Patients Treated for Hodgkin Lymphoma – Experience of the German Hodgkin Lymphoma Study Group (GHSG)

Andreas Engert

https://doi.org/10.4081/hmr.v2i15.605

Published: June 16, 2009

291

PDF: 419
- PDF
Secondary Myeloid Malignancy after Treatment of Acute Lymphoblastic Leukemia (ALL)

Mary V. Relling

https://doi.org/10.4081/hmr.v2i15.607

Published: June 16, 2009

174

PDF: 186
- PDF
Acute leukemia in polycythemia vera

Tiziano Barbui

https://doi.org/10.4081/hmr.v2i15.608

Published: June 16, 2009

208

PDF: 825
- PDF
Secondary myelodysplastic syndrome/acute myeloid leukemia after autologous transplantation

Luca Laurenti, Michela Tarnani, Patrizia Chiusolo, Giuseppe La Torre, Livio Pagano, Gina Zini, Mariagrazia Garzia, Marcella Zollino, Federica Sorà, Giuseppe Leone, Simona Sica

https://doi.org/10.4081/hmr.v2i15.609

Published: June 16, 2009

335

PDF: 337
- PDF
Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 114 adult patients

D Rund, S Krichevsky, S Bar-Cohen, N Goldschmidt, M Kedmi, E Malik, A Gural, S Shafran-Tikva, S Ben-Neriah, D Ben-Yehuda

https://doi.org/10.4081/hmr.v2i15.610

Published: June 16, 2009

337

PDF: 281
- PDF
Should therapy-related myeloid leukemia be treated like de novo acute myeloid leukemia?

Richard A. Larson

https://doi.org/10.4081/hmr.v2i15.611

Published: June 16, 2009

163

PDF: 1250
- PDF
Epigenetic targets for treatment in acute myeloid leukemia

Giuseppe Cimino, Francesco Lo Coco, Clara Nervi

https://doi.org/10.4081/hmr.v2i15.612

Published: June 16, 2009

141

PDF: 311
- PDF
Low dose Azanucleosides for high risk (s)MDS and AML

P.W. Wijermans

https://doi.org/10.4081/hmr.v2i15.613

Published: June 16, 2009

193

PDF: 226
- PDF

Proceedings

Third International Symposium on Secondary Leukemias

Giuseppe Leone

https://doi.org/10.4081/hmr.v2i15.614

Published: June 16, 2009

168

PDF: 263
- PDF